绿原酸联合伏立康唑对大鼠侵袭性肺曲霉病的干预效果及免疫机制

Intervention effect of chlorogenic acid combined with voriconazole on invasive pulmonary aspergillosis in rats and its immune mechanism

  • 摘要: 目的:研究绿原酸(CRA)联合伏立康唑(VRC)对侵袭性肺曲霉病的体内干预效果及免疫机制。方法:将大鼠分为正常对照组、模型组、CRA组、VRC组、联合治疗组(CRA+VRC组),成功建立侵袭性肺曲霉病大鼠模型后,正常对照组和模型组给予生理盐水,其余各组分别给予CRA单药、VRC单药及CRA+VRC联合干预7 d。观察大鼠一般情况以评估全身感染的严重程度;测定大鼠肺组织真菌负荷、肺泡灌洗液中半乳甘露聚糖(GM)含量;采用苏木精—伊红(HE)以及六胺银(PASM)染色观察肺部感染灶病理结构变化;免疫组化法检测CD68、诱导型一氧化氮合酶(i NOS)和精氨酸酶-1(Arg-1)蛋白表达水平;酶联免疫吸附试验(ELISA)检测肺组织匀浆中巨噬细胞的M1表型细胞因子肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)以及M2表型细胞因子白细胞介素-10(IL-10)水平。结果:与模型组比较,CRA+VRC组大鼠一般状况最佳,且体重下降趋势明显减缓(P<0.05),真菌负荷及肺泡灌洗液中GM浓度显著降低(P<0.01)。模型组大鼠肺组织血管、支气管明显受真菌侵袭,大量菌丝、孢子生长,且有广泛炎症、出血,而CRA+VRC组大鼠肺组织则菌丝明显减少,损伤较轻。与模型组比较,CRA+VRC组大鼠肺组织CD68、Arg-1蛋白表达水平显著降低(P<0.01),而i NOS蛋白表达水平显著升高(P<0.05),肺组织TNF-α、IL-6水平均明显升高(P<0.05,P<0.01)。结论:CRA联合VRC对侵袭性肺曲霉病模型大鼠具有协同治疗作用,其作用机制可能与CRA促进巨噬细胞M1表型极化有关。

     

    Abstract: Objective: To explore the intervention effect of chlorogenic acid(CRA) combined with voriconazole(VRC) on invasive pulmonary aspergillosis in vivo and its immune mechanism. Methods: The rats were divided into normal control group, model group, CRA group, VRC group, and combined treatment group(CRA + VRC group). After the successful establishment of the rat model of invasive pulmonary aspergillosis, the normal control group and the model group were treated with normal saline, and the other groups were given CRA alone, VRC alone and combination of the two drugs for 7 days. The general condition of rats was observed to evaluate the severity of systemic infection. The fungal load in lung tissue and galactomannan(GM) content in alveolar lavage fluid were measured. Hematoxylin-eosin(HE)staining and periodic acid-silver methenamine(PASM) staining were used to observe the pathological changes of lung infection. The protein expression levels of CD68, inducible nitric oxide synthase(iNOS) and Arginase 1(Arg-1) were detected by immunohistochemistry. Enzyme-linked immunosorbent assay(ELISA) was used to detect the levels of M1 phenotype cytokines tumor necrosis factor-α(TNF-α), interleukin-6(IL-6) and M2 phenotype cytokines IL-10 of macrophages in lung tissue homogenate. Results: Compared with the model group, the CRA+VRC group had the best general condition, and the trend of weight loss was significantly slowed down(P<0.05), and the fungal load and GM concentration in alveolar lavage fluid were significantly reduced(P<0.01). The pulmonary vessels and bronchus of the lung tissue of rats in the model group were obviously invaded by fungi, a large number of mycelia and spores grew, and there was extensive inflammation and hemorrhage, while in the lung tissue of rats in the CRA+VRC group, mycelia was significantly reduced and the damage was light. Compared with the model group, the expression levels of CD68 and Arg-1 protein in the lung tissue of rats in the CRA+VRC group were significantly decreased(P<0.01), and the expression level of iNOS protein was significantly increased(P<0.05). The levels of TNF-α and IL-6 in lung tissue were significantly increased(P<0.05, P<0.01). Conclusion: CRA combined with VRC has a synergistic therapeutic effect on invasive pulmonary aspergillosis model rats, and its mechanism may be related to CRA promoting the phenotype polarization of macrophage M1.

     

/

返回文章
返回